Graft vs Host Disease: all 815 studies

Page 7 of 9. Open to participants first (138), then studies with results posted, then the rest; newest registration first within each.

• Non-invasive Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft-vs-Host DiseaseStatus unknownNCT01699516
• Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host DiseaseCompletedNCT01699412Phase 3
• Bortezomib in Patients With Chronic Graft Versus Host DiseaseCompletedNCT01672229Phase 1
• Phase I Study of Milatuzumab for Graft Versus Host DiseaseTerminatedNCT01663766Phase 1
• Bone Marrow Stromal Cell Infusions for Stem Cell Transplant ComplicationsCompletedNCT01633229Phase 1
• Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host DiseaseWithdrawnNCT01616680Phase 2
• Brentuximab Vedotin for Steroid Refractory GvHDCompletedNCT01596218Phase 1
• PETCT for Diagnosing and Monitoring Acute GVHDStatus unknownNCT01596192
• Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell TransplantationStatus unknownNCT01596075Phase 1/2
• Mesenchymal Stromal Cells for Acute Graft Versus Host DiseaseStatus unknownNCT01589549Phase 2
• Endomicroscopy and Graft-versus-host DiseaseStatus unknownNCT01583712Not applicable
• Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)WithdrawnNCT01569373
• Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-diseaseStatus unknownNCT01549665Phase 1/2
• Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host DiseaseStatus unknownNCT01526850Phase 2/3
• Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host DiseaseTerminatedNCT01522716Phase 1
• Assessment of MicroRNA Expression in Acute Graft-versus-Host DiseaseCompletedNCT01521039
• Complement and Graft-versus-host DiseaseCompletedNCT01520623Not applicable
• Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After MenarcheCompletedNCT01512498
• PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation BloodCompletedNCT01509560Phase 2
• University of Wisconsin hMSC Cell Bank: Bone Marrow Donor ProtocolCompletedNCT01463475Not applicable
• Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis TreatmentCompletedNCT01460914
• Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis RegimensActive, not recruitingNCT01428973Phase 2
• Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell TransplantationStatus unknownNCT01385124Phase 1/2
• Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)CompletedNCT01379209Phase 1/2
• The Natural History of Graft-Versus-Host Disease in the EyesCompletedNCT01369914
• Efficacy Study of Azithromycin-based Therapy for Bronchiolitis ObliteransTerminatedNCT01327625Not applicable
• Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal PhotophoresisTerminatedNCT01324908Not applicable
• Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)CompletedNCT01318330Phase 1
• Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) PatientsTerminatedNCT01282879Phase 4
• Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological CancersStatus unknownNCT01240525Phase 2
• Cord Blood Serum in the Treatment of Ocular Surface DiseasesCompletedNCT01234623
• Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.CompletedNCT01222039Phase 1/2
• Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host DiseaseCompletedNCT01221766
• Immune Mediated Disorders After Allogeneic Hematopoietic Cell TransplantationCompletedNCT01206309
• Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host DiseaseCompletedNCT01174940Early Phase 1
• Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.CompletedNCT01174277
• Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)Status unknownNCT01158105Phase 2
• Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host DiseaseCompletedNCT01155817Phase 1
• Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)TerminatedNCT01140984Not applicable
• Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)CompletedNCT01135641Phase 2
• A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)TerminatedNCT01066598Phase 2
• Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host DiseaseCompletedNCT01036958
• A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host DiseaseWithdrawnNCT01028313Phase 2
• Pentostatin, Cyclophosphamide Plus Rituximab (PCR) for the Therapy of Poor-Prognosis Chronic Graft-Versus-Host DiseaseWithdrawnNCT01001780Phase 2
• Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell TransplantationCompletedNCT00993343Phase 3
• T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell TransplantStatus unknownNCT00986557Phase 2
• Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host DiseaseStatus unknownNCT00972660Phase 2
• Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)CompletedNCT00967096Phase 1
• Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00957736
• Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell TransplantationCompletedNCT00948727Phase 2
• Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic MalignanciesTerminatedNCT00943293Phase 1
• The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)Status unknownNCT00935324
• Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in AdultsStatus unknownNCT00912067
• Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantCompletedNCT00900406
• Analysis of the Clinical and Histological Correlation of Oral Graft-Versus-Host-Disease (GVHD)CompletedNCT00898885
• Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWithdrawnNCT00898612
• Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)CompletedNCT00887263Phase 3
• Treatment of Steroid Resistant GVHD by Infusion MSCCompletedNCT00827398Phase 1/2
• Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD)No longer availableNCT00826046
• Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host DiseaseStatus unknownNCT00824954Phase 2
• Exploratory Study of Natural Killer Cells in Human SkinCompletedNCT00824889Not applicable
• Study of MEDI 507 in the Treatment of Pediatric PatientsCompletedNCT00813618Phase 1
• Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other DiseasesTerminatedNCT00813501
• Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host DiseaseCompletedNCT00806728Phase 1
• Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD)CompletedNCT00806208Phase 1
• Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host DiseaseCompletedNCT00792246Phase 1
• Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity ConditioningTerminatedNCT00781781Phase 2
• Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell TransplantsCompletedNCT00775632Phase 2
• A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host DiseaseCompletedNCT00760981Phase 1
• Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHDNo longer availableNCT00759018
• Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease TreatmentStatus unknownNCT00749164Phase 1/2
• Stem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersStatus unknownNCT00740467Phase 2
• Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantTerminatedNCT00725062Phase 1
• Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host DiseaseWithdrawnNCT00723593
• Multi Donor Mismatched Stem Cell Transplantation (MDT)Status unknownNCT00716690Phase 1/2
• Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute LeukemiaCompletedNCT00678275Phase 3
• A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) TransplantationCompletedNCT00670423Phase 1
• Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)CompletedNCT00655343Phase 3
• T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
• Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host DiseaseWithdrawnNCT00640497Phase 1/2
• Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host DiseaseCompletedNCT00632658
• A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCTTerminatedNCT00616954Phase 3
• Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host DiseaseCompletedNCT00600314
• Markers of Inflammation in Hematopoietic Stem Cell TransplantCompletedNCT00579397
• Rituximab for GVHDWithdrawnNCT00578591Phase 2
• Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHDCompletedNCT00574470Phase 4
• Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell TransplantationStatus unknownNCT00563589Not applicable
• Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell TransplantationStatus unknownNCT00563108Not applicable
• Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)CompletedNCT00562497Phase 3
• Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHDStatus unknownNCT00524784Phase 1/2
• Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)Status unknownNCT00517907Phase 1
• Feasibility Study of Collecting Multicenter Chronic GVHD DataCompletedNCT00506233
• Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host DiseaseCompletedNCT00504803Phase 2
• Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00489203Phase 2
• Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid MalignanciesTerminatedNCT00473551Phase 1
• Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host DiseaseStatus unknownNCT00472225Phase 2
• Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other DiseaseStatus unknownNCT00462657Not applicable
• Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)TerminatedNCT00454155Phase 1/2
• Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT00450268
• Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem CellStatus unknownNCT00447460Phase 1/2

← Graft vs Host Disease overview